MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20253472

February 25, 2025

Drug Information

布洛芬混悬液

口服混悬剂

100ml:2g

化学药品

February 25, 2025

Company Information

Applicant Company

福建省泉州经济开发区清濛园区雅泰路1号

Manufacturing Company

福建省泉州经济技术开发区清濛园区雅泰路1号1~3栋(1~3号楼)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath